Lupus vaccine study: which pneumonia shot works best?
NCT ID NCT00611663
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study tested two different ways to give pneumococcal vaccines to adults with systemic lupus erythematosus (SLE). One group received a prime-boost strategy (conjugate vaccine first, then polysaccharide vaccine six months later), while the other group got a placebo first and then the standard polysaccharide vaccine. The goal was to see which approach produced a stronger immune response against pneumonia-causing bacteria.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIC Vaccinologie - Hopital Cochin
Paris, 75679, France
Conditions
Explore the condition pages connected to this study.